Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Goldberg

Showing results (961-970 of 1,004) with videos related to

Pageof 101
Sort By:
Neuro-Oncology|May 8, 2014
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomasMatthias A Karajannis, Geneviève Legault, Michael J Fisher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA matchD M Ponce, A Gonzales, M Lubin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host diseaseJenna D Goldberg, Alex Linker, Deborah Kuk, et al.
The Lancet. Haematology|October 10, 2022
Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b-2, open-label studyThomas Martin, Yi Lin, Mounzer Agha, et al.
Molecular Cancer Therapeutics|July 5, 2021
Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or MeningiomaMatthias A Karajannis, Audrey Mauguen, Ekrem Maloku, et al.
Blood|June 26, 2014
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisDamiano Rondelli, Judith D Goldberg, Luis Isola, et al.
Bone Marrow Transplantation|January 12, 2010
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCTM-A Perales, R Jenq, J D Goldberg, et al.
Haematologica|January 29, 2026
Hypomethylating agents plus venetoclax versus intensive chemotherapy in acute myeloid leukemia with chromosome 5 and 7 abnormalitiesLeora Boussi, Jan Philipp Bewersdorf, Yiwen Liu, et al.
Plos One|January 26, 2010
Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042Roy R Chaudhuri, Mohammed Sebaihia, Jon L Hobman, et al.
The Journal of Experimental Medicine|May 2, 2012
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantationRobert R Jenq, Carles Ubeda, Ying Taur, et al.
Pageof 101

Showing results (961-970 of 1,004) with videos related to

Sort By:
Pageof 101
Neuro-Oncology|May 8, 2014
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomasMatthias A Karajannis, Geneviève Legault, Michael J Fisher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA matchD M Ponce, A Gonzales, M Lubin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host diseaseJenna D Goldberg, Alex Linker, Deborah Kuk, et al.
The Lancet. Haematology|October 10, 2022
Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b-2, open-label studyThomas Martin, Yi Lin, Mounzer Agha, et al.
Molecular Cancer Therapeutics|July 5, 2021
Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or MeningiomaMatthias A Karajannis, Audrey Mauguen, Ekrem Maloku, et al.
Blood|June 26, 2014
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisDamiano Rondelli, Judith D Goldberg, Luis Isola, et al.
Bone Marrow Transplantation|January 12, 2010
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCTM-A Perales, R Jenq, J D Goldberg, et al.
Haematologica|January 29, 2026
Hypomethylating agents plus venetoclax versus intensive chemotherapy in acute myeloid leukemia with chromosome 5 and 7 abnormalitiesLeora Boussi, Jan Philipp Bewersdorf, Yiwen Liu, et al.
Plos One|January 26, 2010
Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042Roy R Chaudhuri, Mohammed Sebaihia, Jon L Hobman, et al.
The Journal of Experimental Medicine|May 2, 2012
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantationRobert R Jenq, Carles Ubeda, Ying Taur, et al.
Pageof 101